HIGHLIGHTS
- Indian Government firms are preparing to manufacture Covaxin.
- Covaxin was first developed with seed strains received from the National Institute of Virology (NIV).
- Phase 3 clinical trial of Covaxin was co-funded by ICMR.
- Bharat Biotech agreed to share the vaccine formulation with three companies.
- Bharat Immunologicals and Biologicals Corporation Ltd., Haf....
Tags : Bharat Biotech, coronavirus, COVID-19, Chinavirus, Bharat Immunologicals and Biologicals Corporation Ltd, BIBCOL, Haffkine Biopharmaceutical Corporation Ltd, Indian Immunologicals Ltd, IIL,
comments (0)